SCOTT LEATHAM: Open Payments
NPI 1346770286 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,080 in 121 payments from 21 companies in 2025. Trend: 2023 $4,294 · 2024 $4,473 · 2025 $2,080
Food & beverage: $2,080
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $325 |
| Galderma Laboratories, L.P. | 20 | $251 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $199 |
| PFIZER INC. | 16 | $185 |
| Incyte Corporation | 5 | $183 |
| LEO Pharma Inc. | 7 | $174 |
| Organon LLC | 6 | $124 |
| Lilly USA, LLC | 6 | $120 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| Biofrontera Inc. | 3 | $67 |
Products named: NEMLUVIO, OPZELURA, ADBRY, RINVOQ, ILUMYA, SKYRIZI, LITFULO, VTAMA.
Industry payments across UT — which companies pay providers there.
